ArticleAnnals of the rheumatic diseases2000

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.

F Van den Bosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.